FAQ/Help |
Calendar |
Search |
Today's Posts |
02-02-2015, 12:12 PM | #1 | |||
|
||||
Senior Member
|
Movement Disorders, 01/21/2015 Clinical Article
Pihlstrøm L, et al. – The authors hypothesized that risk variants affect methylation of a putative promoter in SNCA intron 1, previously highlighted in epigenetic studies of Parkinson's disease. The findings support a link between SNCA variability, promoter methylation, and Parkinson's disease risk and indicate that methylation patterns in brain are mirrored in the blood. SNCA methylation warrants further investigation as a potential biomarker. http://www.mdlinx.com/neurology/news...s-on&page_id=2
__________________
In the last analysis, we see only what we are ready to see, what we have been taught to see. We eliminate and ignore everything that is not a part of our prejudices. ~ Jean-Martin Charcot The future is already here — it's just not very evenly distributed. William Gibson |
|||
Reply With Quote |
"Thanks for this!" says: | lab rat (02-02-2015) |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
23 and me - Methylation Analysis | Peripheral Neuropathy | |||
Suzy Cohen on methylation | Peripheral Neuropathy | |||
Neural Correlates of Hypersexuality in Parkinson's Revealed | Parkinson's Disease |